Am­gen's Bob Brad­way takes slight salary dip amid high­er pay among US ex­ecs

Am­gen re­leased its ex­ec­u­tive com­pen­sa­tion num­bers late last week, and while the fil­ing trailed be­hind oth­er Big Phar­mas and biotech com­pa­nies such as Pfiz­er, Mod­er­na, J&J, Sanofi and Hori­zon, Bob Brad­way made more than many in 2022, pulling in just shy of $21.4 mil­lion.

Brad­way’s in­come dropped about $320,000 com­pared to 2021, due to a $298,000 drop from the non-eq­ui­ty in­cen­tive plan, and an $80,000 drop in oth­er com­pen­sa­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER